Advertisement
Singapore markets closed
  • Straits Times Index

    3,292.93
    -3.96 (-0.12%)
     
  • Nikkei

    38,236.07
    -37.98 (-0.10%)
     
  • Hang Seng

    18,475.92
    +268.79 (+1.48%)
     
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • Bitcoin USD

    63,876.62
    +1,300.07 (+2.08%)
     
  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • Dow

    38,675.68
    +450.02 (+1.18%)
     
  • Nasdaq

    16,156.33
    +315.37 (+1.99%)
     
  • Gold

    2,310.10
    +0.50 (+0.02%)
     
  • Crude Oil

    77.99
    -0.96 (-1.22%)
     
  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     
  • FTSE Bursa Malaysia

    1,589.59
    +9.29 (+0.59%)
     
  • Jakarta Composite Index

    7,134.72
    +17.30 (+0.24%)
     
  • PSE Index

    6,615.55
    -31.00 (-0.47%)
     

Best Value Stocks to Buy for April 25th

Here are three stocks with buy rank and strong value characteristics for investors to consider today, April 25th:

Rimini Street, Inc. RMNI: This enterprise software products and services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.6% over the last 60 days.

Rimini Street, Inc. Price and Consensus

Rimini Street, Inc. Price and Consensus
Rimini Street, Inc. Price and Consensus

Rimini Street, Inc. price-consensus-chart | Rimini Street, Inc. Quote

Rimini Street has a price-to-earnings ratio (P/E) of 5.71, compared with 20.04 for the S&P 500. The company possesses a Value Score  of A.

Rimini Street, Inc. PE Ratio (TTM)

Rimini Street, Inc. PE Ratio (TTM)
Rimini Street, Inc. PE Ratio (TTM)

Rimini Street, Inc. pe-ratio-ttm | Rimini Street, Inc. Quote

ADVERTISEMENT

Takeda Pharmaceutical Company Limited TAK: This company that engages in the research, development, manufacture and out-licensing of pharmaceutical products in Japan and globally carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 35.1% over the last 60 days.

Takeda Pharmaceutical Co. Price and Consensus

Takeda Pharmaceutical Co. Price and Consensus
Takeda Pharmaceutical Co. Price and Consensus

Takeda Pharmaceutical Co. price-consensus-chart | Takeda Pharmaceutical Co. Quote

Takeda has a price-to-earnings ratio (P/E) of 10.73, compared with 22.27 for the S&P 500. The company possesses a Value Score of A.

Takeda Pharmaceutical Co. PE Ratio (TTM)

Takeda Pharmaceutical Co. PE Ratio (TTM)
Takeda Pharmaceutical Co. PE Ratio (TTM)

Takeda Pharmaceutical Co. pe-ratio-ttm | Takeda Pharmaceutical Co. Quote

Associated British Foods plc ASBFY: This diversified food, ingredients, and retail company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.

Associated British Foods PLC Price and Consensus

Associated British Foods PLC Price and Consensus
Associated British Foods PLC Price and Consensus

Associated British Foods PLC price-consensus-chart | Associated British Foods PLC Quote

Associated British Foods has a price-to-earnings ratio (P/E) of 14.97, compared with 33.20 for the industry. The company possesses a Value Score of B.

Associated British Foods PLC PE Ratio (TTM)

Associated British Foods PLC PE Ratio (TTM)
Associated British Foods PLC PE Ratio (TTM)

Associated British Foods PLC pe-ratio-ttm | Associated British Foods PLC Quote

 

See the full list of top ranked stocks here.

 

Learn more about the Value score and how it is calculated here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Associated British Foods PLC (ASBFY) : Free Stock Analysis Report

Rimini Street, Inc. (RMNI) : Free Stock Analysis Report

Takeda Pharmaceutical Co. (TAK) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research